The device was not returned for analysis.A review of the lot history record identified one manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified two other similar incidents from this lot.The reported difficulty to remove from the guiding catheter appears to be related to operational context of the procedure due to the reported deflation problem.The investigation determined the reported deflation problem is related to a manufacturing issue.The issue is being addressed per internal operating procedures.Abbott vascular will continue to trend the performance of these devices.On january 15 2020, the abbott vascular determined that a field safety corrective action is required for specific lots of nc trek rx coronary dilatation catheter and nc traveler coronary dilatation catheter.The field safety action number is 2024168-1/29/2020-001-r.This action is being taken as a result of an increase in the complaint trend for reported failures of deflation for nc trek rx and nc traveler rx coronary dilatation catheter.Product from identified lots may exhibit slow, partial or failure to deflate.
|
It was reported that the procedure was to treat a lesion located in the right coronary artery.A xience stent was implanted and then post dilated with a 5.0x15 nc trek balloon dilatation catheter; however, the balloon would not deflate.Several attempts were made to inflate then deflate the balloon, but the balloon would not deflate.Subsequently, the entire system, including the guiding catheter, sheath and the 6fr system were removed as a unit.There was no reported adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
|